The SASP generated by the combination of MEK and a CDK4/6 inhibitor induces the accumulation of CD8+ T cells and makes pancreatic ductal adenocarcinoma more sensitive to immune checkpoint blockade [26]. Here, MAP2K7 is linked to pancreatic ductal adenocarcinoma.